How to grow a small trading account into a $100k?

Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloading stocks at an incredible pace… But I’m not worried at all… Because I don’t hold stocks… Instead I trade in and out of them using a simple strategy that works in bull markets and bear markets. I’ll be breaking down this strategy in a free live broadcast on Thursday, September 12 at 6 PM ET, where I’ll also be giving away $100,000 in gifts to active attendees.

KROS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,002,500.00

Keros Therapeutics Insider Trading History Chart

Keros Therapeutics Share Price & Price History

^$54.75

▲ +0.06 (0.11%)

As of 09/11/2024 01:00 AM ET

Days: 30 | 90 | 365

Invest before this deal closes on 9/18

From Deal Maker | Ad

This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.

Learn more about how you can become a shareholder before their planned Nasdaq listing

Keros Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/13/2024	Carl L Gordon	Director	Sell	250,000	$44.01	$11,002,500.00	119,522
6/8/2023	Keith Regnante	CFO	Sell	20,000	$47.79	$955,800.00
7/15/2022	Jennifer Lachey	Insider	Sell	46,034	$30.00	$1,381,020.00	95,100
7/13/2022	Jennifer Lachey	Insider	Sell	1,916	$30.00	$57,480.00	95,100
5/11/2022	Jennifer Lachey	Insider	Sell	5,300	$41.90	$222,070.00	85,700
4/11/2022	Jennifer Lachey	Insider	Sell	5,300	$62.77	$332,681.00	85,700
4/6/2022	Christopher Rovaldi	COO	Sell	1,728	$65.00	$112,320.00
4/4/2022	Jennifer Lachey	Insider	Sell	7,950	$60.00	$477,000.00	85,700
3/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.38	$141,457.00
2/11/2022	Jennifer Lachey	Insider	Sell	2,650	$52.06	$137,959.00
1/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.75	$142,437.50
1/5/2022	Jennifer Lachey	Insider	Sell	2,650	$60.00	$159,000.00
1/5/2022	Julius Knowles	Director	Sell	4,034	$58.25	$234,980.50
1/3/2022	Julius Knowles	Director	Sell	23,555	$58.01	$1,366,425.55
12/15/2021	Jennifer Lachey	Insider	Sell	735	$50.00	$36,750.00
12/13/2021	Jennifer Lachey	Insider	Sell	1,915	$50.55	$96,803.25
11/10/2021	Jennifer Lachey	Insider	Sell	15,900	$60.00	$954,000.00
11/3/2021	Julius Knowles	Director	Sell	15,967	$41.95	$669,815.65
11/1/2021	Julius Knowles	Director	Sell	23,803	$42.15	$1,003,296.45
10/20/2021	Julius Knowles	Director	Sell	4,082	$38.24	$156,095.68
10/18/2021	Julius Knowles	Director	Sell	13,786	$37.70	$519,732.20
10/14/2021	Julius Knowles	Director	Sell	4,383	$40.13	$175,889.79
10/4/2021	Julius Knowles	Director	Sell	3,746	$40.06	$150,064.76
10/1/2021	Julius Knowles	Director	Sell	6,323	$40.16	$253,931.68
9/27/2021	Julius Knowles	Director	Sell	95,302	$41.17	$3,923,583.34

⭕ [URGENT] Buy Alert just triggered

From Behind the Markets | Ad

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Keros Therapeutics (NASDAQ:KROS)

71.56% of Keros Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Keros Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/20/2024	Nantahala Capital Management LLC	378,807	$17.31M	1.0%	+28.8%	1.050%
8/19/2024	Point72 Asset Management L.P.	370,350	$16.93M	0.0%	-61.9%	1.026%
8/16/2024	Algert Global LLC	15,700	$0.72M	0.0%	+10.6%	0.044%
8/15/2024	Blue Owl Capital Holdings LP	157,633	$7.20M	2.0%	-8.7%	0.437%
8/15/2024	The Manufacturers Life Insurance Company	16,833	$0.77M	0.0%	+17.6%	0.047%
8/15/2024	Dark Forest Capital Management LP	6,355	$0.29M	0.1%	N/A	0.018%
8/15/2024	Darwin Global Management Ltd.	1,525,902	$68.77M	8.0%	+6.3%	4.229%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	2,811	$0.13M	0.0%	N/A	0.008%
8/14/2024	Squarepoint Ops LLC	19,832	$0.91M	0.0%	N/A	0.055%
8/14/2024	Fred Alger Management LLC	48,993	$2.24M	0.0%	-25.6%	0.136%
8/14/2024	Point72 DIFC Ltd	17,540	$0.80M	0.0%	N/A	0.049%
8/14/2024	Marshall Wace LLP	22,377	$1.02M	0.0%	-91.8%	0.062%
8/14/2024	Integral Health Asset Management LLC	85,000	$3.88M	0.4%	+112.5%	0.236%
8/14/2024	ProShare Advisors LLC	5,667	$0.26M	0.0%	-20.6%	0.016%
8/14/2024	Profund Advisors LLC	10,807	$0.49M	0.0%	-42.1%	0.030%
8/12/2024	XTX Topco Ltd	4,996	$0.23M	0.0%	N/A	0.014%
8/9/2024	Renaissance Technologies LLC	14,300	$0.65M	0.0%	N/A	0.040%
8/9/2024	Dimensional Fund Advisors LP	161,715	$7.39M	0.0%	-2.2%	0.448%
8/8/2024	American Century Companies Inc.	298,170	$13.63M	0.0%	+24.9%	0.826%
8/6/2024	Quest Partners LLC	4,809	$0.22M	0.0%	+23,945.0%	0.013%
8/6/2024	Candriam S.C.A.	441,855	$20.19M	0.1%	-32.2%	1.225%
8/5/2024	Arizona State Retirement System	8,077	$0.37M	0.0%	+16.3%	0.022%
8/1/2024	Rhumbline Advisers	41,638	$1.90M	0.0%	+20.6%	0.115%
7/29/2024	Principal Financial Group Inc.	5,265	$0.24M	0.0%	-25.5%	0.015%
7/26/2024	Bank of New York Mellon Corp	118,388	$5.41M	0.0%	+18.8%	0.328%
7/18/2024	Assenagon Asset Management S.A.	24,459	$1.12M	0.0%	N/A	0.068%
7/12/2024	SG Americas Securities LLC	11,633	$0.53M	0.0%	N/A	0.032%
5/29/2024	Opaleye Management Inc.	367,500	$24.33M	5.3%	+2.8%	1.019%
5/16/2024	California State Teachers Retirement System	25,314	$1.68M	0.0%	+14.0%	0.070%
5/16/2024	Bayesian Capital Management LP	4,029	$0.27M	0.0%	N/A	0.011%
5/16/2024	Redmile Group LLC	552,506	$36.58M	1.3%	N/A	1.531%
5/15/2024	Darwin Global Management Ltd.	1,435,950	$95.06M	12.9%	+35.4%	3.979%
5/15/2024	Price T Rowe Associates Inc. MD	1,218,504	$80.67M	0.0%	+17.0%	3.377%
5/14/2024	Platinum Investment Management Ltd.	34,715	$2.30M	0.1%	-29.0%	0.096%
5/14/2024	CANADA LIFE ASSURANCE Co	5,217	$0.35M	0.0%	+117.8%	0.014%
5/14/2024	American International Group Inc.	12,653	$0.84M	0.0%	+13.1%	0.035%
5/13/2024	Ameritas Investment Partners Inc.	2,560	$0.17M	0.0%	+14.5%	0.007%
5/10/2024	Vanguard Group Inc.	1,545,758	$102.33M	0.0%	+7.9%	4.286%
5/8/2024	ProShare Advisors LLC	7,136	$0.47M	0.0%	+26.5%	0.020%
5/8/2024	Russell Investments Group Ltd.	82,352	$5.45M	0.0%	-12.9%	0.228%
5/7/2024	Swiss National Bank	49,900	$3.30M	0.0%	+22.0%	0.138%
5/3/2024	GSA Capital Partners LLP	8,538	$0.57M	0.0%	+25.5%	0.024%
5/2/2024	FORA Capital LLC	8,480	$0.56M	0.0%	N/A	0.024%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	13,149	$0.87M	0.0%	+1.9%	0.036%
4/29/2024	Principal Financial Group Inc.	7,063	$0.47M	0.0%	+8.8%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	6,916	$0.46M	0.1%	+99.9%	0.019%
4/25/2024	WCM Investment Management LLC	117,030	$7.75M	0.0%	-24.3%	0.324%
4/10/2024	Perpetual Ltd	6,689	$0.44M	0.0%	N/A	0.019%
2/15/2024	Opaleye Management Inc.	357,500	$14.21M	3.8%	-0.8%	1.193%
2/15/2024	Parkman Healthcare Partners LLC	360,467	$14.33M	2.0%	+20.8%	1.203%
2/14/2024	ADAR1 Capital Management LLC	688,316	$27.37M	9.8%	N/A	2.297%
2/14/2024	Braidwell LP	1,118,961	$44.49M	1.6%	-17.6%	3.735%
2/14/2024	Superstring Capital Management LP	74,649	$2.97M	2.1%	N/A	0.249%
2/14/2024	Platinum Investment Management Ltd.	48,883	$1.94M	0.1%	N/A	0.163%
2/13/2024	Rafferty Asset Management LLC	65,281	$2.60M	0.0%	+12.2%	0.218%
2/9/2024	Franklin Resources Inc.	699,425	$27.81M	0.0%	+47.9%	2.335%
2/9/2024	UBS Group AG	181,385	$7.21M	0.0%	+2,653.7%	0.605%
2/6/2024	Charles Schwab Investment Management Inc.	181,578	$7.22M	0.0%	+2.6%	0.606%
2/6/2024	Amalgamated Bank	3,122	$0.12M	0.0%	-6.2%	0.010%
2/6/2024	Swiss National Bank	40,900	$1.63M	0.0%	-10.3%	0.137%
2/5/2024	Russell Investments Group Ltd.	94,557	$3.76M	0.0%	+24.6%	0.316%
1/29/2024	WCM Investment Management LLC	154,664	$6.35M	0.0%	+58.6%	0.516%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	12,898	$0.51M	0.0%	+3.2%	0.043%
1/24/2024	Arizona State Retirement System	5,805	$0.23M	0.0%	N/A	0.019%
1/24/2024	China Universal Asset Management Co. Ltd.	3,460	$0.14M	0.0%	+356.5%	0.012%
1/12/2024	SG Americas Securities LLC	12,252	$0.49M	0.0%	-74.0%	0.041%
12/18/2023	Vanguard Group Inc.	1,406,431	$44.84M	0.0%	+18.8%	4.694%
11/14/2023	Braidwell LP	1,357,309	$43.27M	1.3%	+18.7%	4.531%
11/14/2023	Schonfeld Strategic Advisors LLC	77,800	$2.48M	0.0%	-10.3%	0.260%
11/14/2023	Profund Advisors LLC	10,021	$0.32M	0.0%	-22.5%	0.033%
11/13/2023	CHI Advisors LLC	407,633	$13M	3.9%	+1.4%	1.361%
11/13/2023	Algert Global LLC	10,635	$0.34M	0.0%	-35.9%	0.035%
11/13/2023	FMR LLC	3,604,928	$114.93M	0.0%	-11.2%	12.032%
11/13/2023	Rafferty Asset Management LLC	58,189	$1.86M	0.0%	-17.2%	0.194%
11/9/2023	Citigroup Inc.	98,109	$3.13M	0.0%	-35.8%	0.327%
11/8/2023	Charles Schwab Investment Management Inc.	176,953	$5.64M	0.0%	+19.7%	0.597%
11/8/2023	Swiss National Bank	45,600	$1.45M	0.0%	+4.8%	0.154%
11/7/2023	Barclays PLC	49,511	$1.58M	0.0%	+29.0%	0.167%
10/27/2023	TD Asset Management Inc	36,200	$1.15M	0.0%	+100.0%	0.122%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	12,494	$0.40M	0.0%	+8.2%	0.042%
10/24/2023	Bank of New York Mellon Corp	144,409	$4.60M	0.0%	+42.1%	0.487%
10/13/2023	SG Americas Securities LLC	47,183	$1.50M	0.0%	+466.7%	0.159%
10/10/2023	WCM Investment Management LLC	97,542	$3.11M	0.0%	+2.4%	0.329%
8/22/2023	CHI Advisors LLC	402,118	$16.16M	4.9%	+54.0%	1.356%
8/15/2023	Braidwell LP	1,143,865	$45.96M	1.5%	N/A	3.857%
8/11/2023	Campbell & CO Investment Adviser LLC	7,745	$0.31M	0.1%	N/A	0.026%
8/11/2023	B. Metzler seel. Sohn & Co. AG	26,256	$1.06M	0.0%	+113.2%	0.089%
8/10/2023	Profund Advisors LLC	12,935	$0.52M	0.0%	+9.2%	0.044%
8/10/2023	Russell Investments Group Ltd.	68,562	$2.76M	0.0%	+23.3%	0.232%
8/10/2023	Meitav Investment House Ltd.	1,597	$64K	0.0%	N/A	0.005%
8/10/2023	Citigroup Inc.	152,847	$6.14M	0.0%	-53.1%	0.517%
8/9/2023	Swiss National Bank	43,500	$1.75M	0.0%	+21.8%	0.147%
8/8/2023	Candriam S.C.A.	721,061	$28.97M	0.2%	-3.2%	2.438%
8/7/2023	Principal Financial Group Inc.	6,612	$0.27M	0.0%	+12.5%	0.022%
8/4/2023	American International Group Inc.	10,834	$0.44M	0.0%	+16.7%	0.037%
8/3/2023	Bank of New York Mellon Corp	101,638	$4.08M	0.0%	-23.3%	0.344%
8/2/2023	Handelsbanken Fonder AB	6,700	$0.27M	0.0%	-8.2%	0.023%
8/1/2023	Arizona State Retirement System	5,611	$0.23M	0.0%	+17.2%	0.019%
7/31/2023	Strs Ohio	5,700	$0.23M	0.0%	+7.5%	0.019%
7/27/2023	Virtu Financial LLC	8,708	$0.35M	0.0%	N/A	0.029%

Data available starting January 2016

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-012, which is in Phase II clinical trial to treat pulmonary arterial hypertension and cardiovascular disorders; and KER-065 that is in Phase I clinical trial for the treatment of obesity and neuromuscular diseases. In addition, the company has collaboration and license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize KER-050 and licensed products containing KER-050. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $54.75

$53.60

$55.20

50 Day Range

MA: $47.77

$41.68

$54.75

52 Week Range

Now: $54.75

$27.02

$73.00

Volume

289,765 shs

Average Volume

373,756 shs

Market Capitalization

$1.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Keros Therapeutics?: Keros Therapeutics' top insider shareholders include:
Carl L Gordon (Director)
Keith Regnante (CFO)
Learn More about top insider investors at Keros Therapeutics.
Who are the major institutional investors of Keros Therapeutics?: Keros Therapeutics' top institutional shareholders include:
Darwin Global Management Ltd. — 4.23%
Candriam S.C.A. — 1.22%
Nantahala Capital Management LLC — 1.05%
Point72 Asset Management L.P. — 1.03%
American Century Companies Inc. — 0.83%
Dimensional Fund Advisors LP — 0.45%
Learn More about top institutional investors of Keros Therapeutics stock.
Which major investors are selling Keros Therapeutics stock?: Within the last quarter, KROS stock was sold by these institutional investors:
Point72 Asset Management L.P.
Marshall Wace LLP
Candriam S.C.A.
Fred Alger Management LLC
Blue Owl Capital Holdings LP
Profund Advisors LLC
Dimensional Fund Advisors LP
Principal Financial Group Inc.
Which major investors are buying Keros Therapeutics stock?: Within the previous quarter, KROS stock was bought by institutional investors including:
Darwin Global Management Ltd.
Nantahala Capital Management LLC
American Century Companies Inc.
Integral Health Asset Management LLC
Assenagon Asset Management S.A.
Squarepoint Ops LLC
Bank of New York Mellon Corp
Point72 DIFC Ltd